Sign in
4

Changes in Ownership

Amylyx Pharmaceuticals, Inc. Filed Acc 0001193125-26-359678

Co-Chief Executive Officer acquired 60,039 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Klee Justin B. · Co-Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-08-18 Grant or award : show line 1 in the form +60,039 3,643,520 D
Loading xslF345X06/ownership.xml…